Description Introducing GHK-Cu 100mg from SSP Research, a naturally occurring copper peptide GHK-Cu renowned for its exceptional roles in skin regeneration, tissue healing, and inflammation modulation
Here are some of its competitors that are already FDA approved for weight management: Liraglutide (Saxenda) : This injectable medication is a once-daily GLP-1 receptor agonist approved for chronic weight management in adults with a body mass index (BMI) of 30 or greater (obesity) or 27 or greater (overweight) with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
Thyroid Peroxidase Antibodies (TPO): Another thyroid antibody often elevated alongside TgAb in Hashimotos
Some GLP-1 Drugs Target More Than One Hormone GLP-1 drugs can be single, dual, or triple agonists, depending on how many hormones they target
We are located in Franklin, Milwaukee, Menomonee Falls, and Waukesha, Wisconsin